| Literature DB >> 33941502 |
Siobhán B Carr1, Rebecca Cosgriff2, Satenik Harutyunyan1, Peter G Middleton1, Rasa Ruseckaite1, Susannah Ahern1, Géraldine Daneau1, Luiz Vicente R F da Silva Filho1, Anne L Stephenson1, Stephanie Y Cheng1, Joel Melo1, Harriet Corvol1, Pierre-Régis Burgel1, Lutz Nährlich1, Edward McKone1, Carla Colombo1, Marco Salvatore1, Rita Padoan1, Olzhas Abdrakhmanov1, Vincent Gulmans1, Catherine A Byrnes1, Elena Amelina1, Elena Kondratyeva1, Elena Zhekayte1, Nataliya Kashirskaya1, Marco Zampoli1, M Dolores Pastor-Vivero1, Pedro Mondejar-Lopez1, Isabelle de Monestrol1, Andeas Jung1, Elliot McClenaghan1, Keith Brownlee1, Samar Rizvi1, Christopher H Goss1, Alexander Elbert1, Albert Faro1, Hector Gutierrez1, Bruce C Marshall1.
Abstract
Entities:
Keywords: COVID; Coronavirus; Cystic fibrosis; Vaccine
Year: 2021 PMID: 33941502 DOI: 10.1016/j.jcf.2021.03.028
Source DB: PubMed Journal: J Cyst Fibros ISSN: 1569-1993 Impact factor: 5.482